Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
admin Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read MorePfizer
Pfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states
Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in…
Read MorePfizer agrees to buy Global Blood Therapeutics in deal valued at $5.4 billion: WSJ
Pfizer Inc. PFE, -1.18% has reached an agreement to buy Global Blood Therapeutics Inc. in…
Read MoreModerna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
Moderna MRNA, +3.81% and Pfizer PFE, -0.41% have not yet started clinical trials for the…
Read MorePfizer reports big profit and revenue beats, as COVID drug sales increase by nearly $9 billion
Shares of Pfizer Inc. PFE, -2.30% gained 0.3% in premarket trading Thursday, after the pharmaceutical…
Read MorePfizer submits a new NDA to FDA for COVID-19 pill PAXLOVID
Pfizer Inc. PFE, +0.55% said Thursday that it has submitted a New Drug Application (NDA)…
Read More